Kembali ke Daftar Obat

Panduan penyiapan dan pemberian terapi medikasi
Ketorolac

Penyiapan

Sediaan

  • 30 mg/mL

Rekomendasi Pengenceran (Konsentrasi)

dapat digunakan tanpa diencerkan

Pelarut

  • D5%
  • NaCl 0.9%
  • RL

Pemberian

Rekomendasi Akses

IV
IM

Rekomendasi Durasi Pemberian

Bolus 15 detik

Stabilitas Obat Setelah Rekonstruksi

terlindungi dari cahaya

Keamanan

pH

6,9-7,0
pH risiko rendah (5,0-7,5)

Osmolaritas Sebelum Pengenceran

290
Osmolaritas rendah (<600)

Phlebitis

Tidak

Inkompatibilitas

  • Morphine
  • Pethidine
  • Promethazine
  • Hydroxyzine
  • Cyclizine lactate
  • Haloperidol lactate
  • Hydroxyzine HCl
  • Nalbuphine HCl
  • Azithromycin
  • Cisatracurium besylate
  • Fenoldopam mesylate

Klasifikasi GHS

Acute Toxicity
Irritant

Manifestasi GHS

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
H315 (28.6%): Causes skin irritation [Warning Skin corrosion/irritation]
H319 (28.6%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
H335 (28.6%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

Sumber

  • American Society of Health-System Pharmacists. 2021. ASHP® Injectable Drug Information: A Comprehensive Guide to Compatibility and Stability. 2021 Edition. eBook. American Society of Health-System Pharmacists. ISBN: 978-1-58528-690-4. doi.org/10.37573/9781585286850